Hypophosphatemia
Description
• Hypophophatemia:
• Is a serum phosphorus level lower than 2.7
  mg/dL
• A decrease in the serum phosphorus level is
  accompanied by an increase in the serum
  calcium
Causes
• Insufficient phosphorus intake: malnutrition and
  starvation
• Increased phosphorus excretion
   – Hyperparathyroidism
   – Malignancy
   – Use of aluminum hydroxide-based or magnesium
     based antacids
• Intracellular shift
   – Hyperglycemia
   – Respiratory alkalosis
Assessment
• Cardiovascular
    – Decreased contractility and cardiac output
    – Slowed peripheral pulses
• Respiratory: shallow respirations
• Neuromuscular
    – Weakness
    – Decreased deep tendon reflexes
    – Decreased bone density that can cause fractures and alterations in bone
      shape
    – Rhabdomyolysis
• Central Nervous System
    – Irritability
    – Confusion
    – Seizures
• Hematological
    – Decreased platelet aggregation and increased bleeding
    – Immunosuppression
Interventions
• 2.7 – 4.5
• Monitor cardiovascular, respiratory, neuromuscular, CNS, &
  hematological status
• Discontinue medications that contribute
• Administer phosphorus orally w/vitamin D supplement
• Prepare to administer phosphorus IV when serum levels fall below
  1mg/dL and critical clinical manifestations
• Administer IV phosphorus slowly because of the risks associated
• Assess renal system before administering
• Move client carefully, & monitor for signs of a fracture
• Instruct client to increase intake of phosphorus containing foods
  while decreasing intake of calcium containing foods
• Common Phosphorus Food Sources:
• Fish, organ meats, nuts, pork, beef, chicken, whole-grain breads and
  cereals

Hypophosphatemia

  • 1.
  • 2.
    Description • Hypophophatemia: • Isa serum phosphorus level lower than 2.7 mg/dL • A decrease in the serum phosphorus level is accompanied by an increase in the serum calcium
  • 3.
    Causes • Insufficient phosphorusintake: malnutrition and starvation • Increased phosphorus excretion – Hyperparathyroidism – Malignancy – Use of aluminum hydroxide-based or magnesium based antacids • Intracellular shift – Hyperglycemia – Respiratory alkalosis
  • 4.
    Assessment • Cardiovascular – Decreased contractility and cardiac output – Slowed peripheral pulses • Respiratory: shallow respirations • Neuromuscular – Weakness – Decreased deep tendon reflexes – Decreased bone density that can cause fractures and alterations in bone shape – Rhabdomyolysis • Central Nervous System – Irritability – Confusion – Seizures • Hematological – Decreased platelet aggregation and increased bleeding – Immunosuppression
  • 5.
    Interventions • 2.7 –4.5 • Monitor cardiovascular, respiratory, neuromuscular, CNS, & hematological status • Discontinue medications that contribute • Administer phosphorus orally w/vitamin D supplement • Prepare to administer phosphorus IV when serum levels fall below 1mg/dL and critical clinical manifestations • Administer IV phosphorus slowly because of the risks associated • Assess renal system before administering • Move client carefully, & monitor for signs of a fracture • Instruct client to increase intake of phosphorus containing foods while decreasing intake of calcium containing foods • Common Phosphorus Food Sources: • Fish, organ meats, nuts, pork, beef, chicken, whole-grain breads and cereals